title: Drive-through angioplasty: is it safe or necessary?
authors.forename: Timothy A
authors.initials: TA
authors.lastname: Mixon
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Dehmer
mesh_terms: D000077284:Abciximab; D000556:Ambulatory Surgical Procedures; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D003362:Cost-Benefit Analysis; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D017534:Radial Artery; D012449:Safety; D015607:Stents
chemical_list: D000911:Antibodies, Monoclonal; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000077284:Abciximab